Login
EN
[EN] English
[FR] Français
Login
EN
[EN] English
[FR] Français
Give us feedback
Explore
Search
Special collections
Statistics
News
Help
Start on ORBi
Deposit
Profile
Publication List
Add your ORCID
FAQ: FWB Open Access Decree
Tutorials
Legal Information
Training sessions
About
What's ORBi ?
Impact and visibility
Around ORBi
About statistics
About metrics
OAI-PMH
ORBi team
Release Notes
Back
Home
OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX AND AZACITIDINE IN REAL-WORLD BELGIAN CLINICAL PRACTICE - 2025
Download
Poster (Scientific congresses and symposiums)
OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX AND AZACITIDINE IN REAL-WORLD BELGIAN CLINICAL PRACTICE
De Voeght, Adrien
;
Aaron D. Goldberg
;
Florence Van Obbergh
et al.
2025
•
EHA2025
Peer reviewed
Permalink
https://hdl.handle.net/2268/337298
Files (1)
Send to
Details
Statistics
Bibliography
Similar publications
Files
Full Text
Poster_EHA_ADV.pdf
Author postprint (2.2 MB)
Download
All documents in ORBi are protected by a
user license
.
Send to
RIS
BibTex
APA
Chicago
Permalink
X
Linkedin
copy to clipboard
copied
Details
Keywords :
Real Word Evidence; Acute myeloid leukemia; Venetoclax; antifungal
Disciplines :
Hematology
Author, co-author :
De Voeght, Adrien
;
Université de Liège - ULiège > Département des sciences cliniques
Aaron D. Goldberg
Florence Van Obbergh
Nathan De Beule
Laura Vandeweerd
Barbara Gillon
Yanqing Xu
Rebecca Burne
Johan Maertens
Language :
English
Title :
OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX AND AZACITIDINE IN REAL-WORLD BELGIAN CLINICAL PRACTICE
Publication date :
2025
Event name :
EHA2025
Event organizer :
European Hematology Society
Event date :
June 12-15
Audience :
International
Peer review/Selection committee :
Peer reviewed
Available on ORBi :
since 04 November 2025
Statistics
Number of views
31 (0 by ULiège)
Number of downloads
33 (0 by ULiège)
More statistics
Bibliography
Similar publications
Contact ORBi